Quantcast

Latest Neuropathic pain Stories

2014-07-20 23:02:11

ReportsnReports.com adds “Cebranopadol (Neuropathic Pain) - Forecast and Market Analysis to 202” to its store. Dallas, TX (PRWEB) July 20, 2014 Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Although the term neuropathic...

2014-07-16 08:27:08

MENLO PARK, Calif., July 16, 2014 /PRNewswire/ -- Virobay, Inc., a clinical stage pharmaceutical company with a platform of cathepsin protease inhibitors being developed for the treatment of neuropathic pain, autoimmune disease and fibrosis, today announced the closing of an expanded Series B second tranche financing of $8.0 million. Including this recent $8 million investment, Virobay has raised an aggregate of $18 million in two tranches of the Series B financing. The first tranche...

2014-06-30 12:31:31

Insurance Giant to Reimburse NYC Rehabilitation Center for Its Calmare Therapy Treatments FAIRFIELD, Conn., June 30, 2014 /PRNewswire/ -- The Calmare(®) Pain Therapy Device, the flagship product of Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), the pain mitigation company, gained a favorable reimbursement ruling from the New York City Civil Courts in a personal injury case against Allstate Insurance, Co., (Allstate). In the ruling, the Court instructed the insurance giant to...

2014-06-26 08:27:08

Top-line results anticipated by end-of-year RALEIGH, N.C., June 26, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has completed enrollment of all patients required for its initial Phase 3 study of Clonidine Topical Gel for the treatment of painful diabetic neuropathy (PDN). http://photos.prnewswire.com/prnvar/20110217/CL49801LOGO The Phase 3 trial is a multicenter, randomized, double-blind, placebo-controlled study to determine the...

2014-06-25 23:08:04

Transparency Market Research has announced the addition of the "Pain Management Therapeutics Market: Global Industry Analysis, Size, Share, Growth and Forecast 2012 - 2018" report to their offering. Browse the full report: http://www.transparencymarketresearch.com/pain-management-therapeutics.html. Albany, New York (PRWEB) June 25, 2014 The global pain management therapeutics market is expected to witness a decline during the forecast period (2012 to 2018) due to patent...

2014-06-25 12:30:48

MENLO PARK, Calif., June 25, 2014 /PRNewswire/ -- Virobay, Inc., a clinical stage pharmaceutical company with a broad platform of cathepsin protease inhibitors being developed for the treatment of neuropathic pain, autoimmune diseases and fibrosis, today announced the appointment of James Welch as Chief Financial Officer, effective as of June 20, 2014. Mr. Welch has more than 20 years of experience in financial and operational management at life science and high technology firms....

2014-06-23 12:29:32

DUBLIN, June 23, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/s4hmm7/global_pain) has announced the addition of the "Global Pain Management Devices Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 SCS therapy is becoming increasingly popular for the treatment of chronic, refractory, and neuropathic pain. Pain management therapy using SCS devices involves MI implantation of electrodes into the epidural...

2014-06-19 23:14:34

Global Pain Management Devices Market 2014-2018 report analyzes Neurostimulation Devices (SCS, DBS and SNS devices), Electrical Stimulation Devices (TENS devices), and Analgesic Infusion Pumps (PCA and Intrathecal pumps). Dallas, Texas (PRWEB) June 19, 2014 SCS therapy is becoming increasingly popular for the treatment of chronic, refractory, and neuropathic pain. Pain management therapy using SCS devices involves MI implantation of electrodes into the epidural space near the source of...

2014-06-19 16:26:04

SAN FRANCISCO, June 19, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported that partner AstraZeneca today announced that the New England Journal of Medicine (NEJM) has published results of two pivotal Phase III studies - KODIAC-4 and KODIAC-5 of naloxegol, an investigational treatment for opioid-induced constipation (OIC). Opioids play an important role in chronic pain relief by binding to mu-receptors in the brain, but they also bind to mu-receptors in the bowel. That is why...

2014-06-16 04:21:31

CAMBRIDGE, England, June 16, 2014 /PRNewswire/ -- Convergence Pharmaceuticals ("Convergence" or "the Company") Highlights of the data: - CNV1014802 was associated with a consistent reduction of pain severity and number of paroxysms in all primary and secondary outcomes - 2.3 unit reduction in numeric rating scale (NRS) of pain intensity compared to placebo...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related